Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 12, 2011 - Issue 17
Submit an article Journal homepage
523
Views
32
CrossRef citations to date
0
Altmetric
Reviews

Blockade of cytotoxic T-lymphocyte antigen-4 as a new therapeutic approach for advanced melanoma

Xiang-Yang WangDepartment of Human and Molecular Genetics;VCU Institute of Molecular Medicine; VCU Massey Cancer Center, Virginia Commonwealth University School of Medicine, Richmond, VA 23298, USA +1 804 828 9632 (Paul B Fischer); +1 804 628 2679 (Xiang-Yang Wang); [email protected]; [email protected]
, PhD,
Daming ZuoSouthern Medical University, Department of Immunology, Guangzhou, 510515, China
, PhD,
Devanand SarkarDepartment of Human and Molecular Genetics;VCU Institute of Molecular Medicine; VCU Massey Cancer Center, Virginia Commonwealth University School of Medicine, Richmond, VA 23298, USA +1 804 828 9632 (Paul B Fischer); +1 804 628 2679 (Xiang-Yang Wang); [email protected]; [email protected]
, MBBS PhD &
Paul B FisherDepartment of Human and Molecular Genetics;VCU Institute of Molecular Medicine; VCU Massey Cancer Center, Virginia Commonwealth University School of Medicine, Richmond, VA 23298, USA +1 804 828 9632 (Paul B Fischer); +1 804 628 2679 (Xiang-Yang Wang); [email protected]; [email protected]
, MPh PhD
Pages 2695-2706 | Published online: 11 Nov 2011

Citations (32)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Sara Tomei, Ena Wang, Lucia Gemma Delogu, Francesco M Marincola & Davide Bedognetti. (2014) Non-BRAF-targeted therapy, immunotherapy, and combination therapy for melanoma. Expert Opinion on Biological Therapy 14:5, pages 663-686.
Read now
Shilpa Bhatia, Luni Emdad, Swadesh K Das, Hossein Hamed, Paul Dent, Devanand Sarkar & Paul B Fisher. (2014) Non-BRAF targeted therapies for melanoma: protein kinase inhibitors in Phase II clinical trials. Expert Opinion on Investigational Drugs 23:4, pages 489-500.
Read now

Articles from other publishers (30)

Hongbin Wang, Tuan T. Tran, Katherine T. Duong, Trieu Nguyen & Uyen M. Le. (2022) Options of Therapeutics and Novel Delivery Systems of Drugs for the Treatment of Melanoma. Molecular Pharmaceutics 19:12, pages 4487-4505.
Crossref
Mungyo Jung, Mikyung Kang, Byung‐Seok Kim, Jihye Hong, Cheesue Kim, Choong‐Hyun Koh, Garam Choi, Yeonseok Chung & Byung‐Soo Kim. (2022) Nanovesicle‐Mediated Targeted Delivery of Immune Checkpoint Blockades to Potentiate Therapeutic Efficacy and Prevent Side Effects. Advanced Materials 34:9, pages 2106516.
Crossref
Ritopa Das, Sofia Langou, Thinh T. Le, Pooja Prasad, Feng Lin & Thanh D. Nguyen. (2022) Electrical Stimulation for Immune Modulation in Cancer Treatments. Frontiers in Bioengineering and Biotechnology 9.
Crossref
Xuan Lin, Hedan Chen, Ying Xie, Xue Zhou, Yun Wang, Jing Zhou, Shiqi Long, Zuquan Hu, Shichao Zhang, Wei Qiu, Zhu Zeng & Lina Liu. (2022) Combination of CTLA-4 blockade with MUC1 mRNA nanovaccine induces enhanced anti-tumor CTL activity by modulating tumor microenvironment of triple negative breast cancer. Translational Oncology 15:1, pages 101298.
Crossref
Sashana Dixon, Alice Tran, Matthew Schrier & Malav Trivedi. 2022. Engineering Technologies and Clinical Translation. Engineering Technologies and Clinical Translation 331 356 .
Biswajit Mukherjee, Ashique Al Hoque, Apala Chakraborty, Samrat Chakraborty, Lopamudra Dutta, Debasmita Dutta, Soumyabrata Banerjee, Moumita Dhara & R. Manasa Deepa. 2022. Nanotherapeutics in Cancer Vaccination and Challenges. Nanotherapeutics in Cancer Vaccination and Challenges 29 75 .
Andriani Charalambous & Mark-Alexander Schwarzbich. 2022. Handbook of Cancer and Immunology. Handbook of Cancer and Immunology 1 42 .
Renske J. E. van den Bijgaart, Fabian Schuurmans, Jurgen J. Fütterer, Marcel Verheij, Lenneke A. M. Cornelissen & Gosse J. Adema. (2021) Immune Modulation Plus Tumor Ablation: Adjuvants and Antibodies to Prime and Boost Anti-Tumor Immunity In Situ. Frontiers in Immunology 12.
Crossref
Marc Armengol, Juliana Carvalho Santos, Miranda Fernández-Serrano, Núria Profitós-Pelejà, Marcelo Lima Ribeiro & Gaël Roué. (2021) Immune-Checkpoint Inhibitors in B-Cell Lymphoma. Cancers 13:2, pages 214.
Crossref
Kyusang Hwang, Jin Hwan Yoon, Ji Hyun Lee & Sukmook Lee. (2021) Recent Advances in Monoclonal Antibody Therapy for Colorectal Cancers. Biomedicines 9:1, pages 39.
Crossref
Sanyog Jain, Kaisar Raza, Ashish Kumar Agrawal & Ankur Vaidya. 2021. Nanotechnology Applications for Cancer Chemotherapy. Nanotechnology Applications for Cancer Chemotherapy 141 174 .
Jing Jin & Qijie Zhao. (2020) Engineering nanoparticles to reprogram radiotherapy and immunotherapy: recent advances and future challenges. Journal of Nanobiotechnology 18:1.
Crossref
Yuka Igarashi & Tetsuro Sasada. (2020) Cancer Vaccines: Toward the Next Breakthrough in Cancer Immunotherapy. Journal of Immunology Research 2020, pages 1-13.
Crossref
Alexandra L. Lewis, Jamie Chaft, Monica Girotra & Gregory W. Fischer. (2020) Immune checkpoint inhibitors: a narrative review of considerations for the anaesthesiologist. British Journal of Anaesthesia 124:3, pages 251-260.
Crossref
Chunqing Guo, Shixian Chen, Wenjie Liu, Yibao Ma, Juan Li, Paul B. Fisher, Xianjun Fang & Xiang-Yang Wang. 2019. Immunotherapy of Cancer. Immunotherapy of Cancer 195 253 .
Qianyu Guo, Fan Huang, Christophe Goncalves, Sonia V. del Rincón & Wilson H. MillerJrJr. 2019. Immunotherapy of Cancer. Immunotherapy of Cancer 1 62 .
Ti-Kun Fang, Cheng-Jun Yan & Juan Du. (2018) CTLA-4 methylation regulates the pathogenesis of myasthenia gravis and the expression of related cytokines. Medicine 97:18, pages e0620.
Crossref
Lina Liu, Yuhua Wang, Lei Miao, Qi Liu, Sara Musetti, Jun Li & Leaf Huang. (2018) Combination Immunotherapy of MUC1 mRNA Nano-vaccine and CTLA-4 Blockade Effectively Inhibits Growth of Triple Negative Breast Cancer. Molecular Therapy 26:1, pages 45-55.
Crossref
Sadamu Homma, Kazumi Hayashi, Kosaku Yoshida, Yukiko Sagawa, Yuko Kamata & Masaki Ito. (2018) Nafamostat mesilate, a serine protease inhibitor, suppresses interferon-gamma-induced up-regulation of programmed cell death ligand 1 in human cancer cells. International Immunopharmacology 54, pages 39-45.
Crossref
James S. Killinger, Caitlin Hurley, Emily Wasserman & Jennifer McArthur. (2017) Complications of Emerging Oncology Therapies Requiring Treatment in the Pediatric Intensive Care Unit. Current Pediatrics Reports 5:4, pages 220-227.
Crossref
Mehrnaz Narooie‑Nejad, Omid Taji, Dor Kordi Tamandani & Mahmoud Kaykhaei. (2016) Association of CTLA-4 gene polymorphisms -318C/T and +49A/G and Hashimoto's thyroidits in Zahedan, Iran. Biomedical Reports.
Crossref
S. Talukdar, L. Emdad, S.K. Das, D. Sarkar & P.B. Fisher. 2016. 159 191 .
Maria Teresa P. de Aquino, Anshu Malhotra, Manoj K. Mishra & Anil Shanker. (2015) Challenges and future perspectives of T cell immunotherapy in cancer. Immunology Letters 166:2, pages 117-133.
Crossref
Yu-Lun Kuo, Chun-Houh Chen, Tsung-Hsien Chuang, Wei-Kai Hua, Wey-Jinq Lin, Wei-Hsiang Hsu, Peter Mu-Hsin Chang, Shih-Lan Hsu, Tse-Hung Huang, Cheng-Yan Kao & Chi-Ying F. Huang. (2015) Gene Expression Profiling and Pathway Network Analysis Predicts a Novel Antitumor Function for a Botanical-Derived Drug, PG2. Evidence-Based Complementary and Alternative Medicine 2015, pages 1-15.
Crossref
Davide Bedognetti, Sara Tomei, Wouter Hendrickx, Francesco M. Marincola & Ena Wang. 2015. Developments in T Cell Based Cancer Immunotherapies. Developments in T Cell Based Cancer Immunotherapies 99 127 .
Yves Sucaet & Wim WaelputYves Sucaet & Wim Waelput. 2014. Digital Pathology. Digital Pathology 57 69 .
Simone Mocellin & Donato Nitti. (2013) CTLA-4 blockade and the renaissance of cancer immunotherapy. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1836:2, pages 187-196.
Crossref
Lifang Xie & Frank L. Meyskens. (2013) The pan-Aurora kinase inhibitor, PHA-739358, induces apoptosis and inhibits migration in melanoma cell lines. Melanoma Research 23:2, pages 102-113.
Crossref
Michael Croft, Chris A. Benedict & Carl F. Ware. (2013) Clinical targeting of the TNF and TNFR superfamilies. Nature Reviews Drug Discovery 12:2, pages 147-168.
Crossref
Chunqing Guo, Masoud H. Manjili, John R. Subjeck, Devanand Sarkar, Paul B. Fisher & Xiang-Yang Wang. 2013. 421 475 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.